AMBARELLA INC (AMBA) Fundamental Analysis & Valuation

NASDAQ:AMBA • KYG037AX1015

Current stock price

50.73 USD
-0.35 (-0.69%)
Last:

This AMBA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AMBA Profitability Analysis

1.1 Basic Checks

  • In the past year AMBA was profitable.
  • In the past year AMBA had a positive cash flow from operations.
  • AMBA had negative earnings in each of the past 5 years.
  • Of the past 5 years AMBA 4 years had a positive operating cash flow.
AMBA Yearly Net Income VS EBIT VS OCF VS FCFAMBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50M -50M 100M -100M -150M

1.2 Ratios

  • AMBA's Return On Assets of -10.60% is on the low side compared to the rest of the industry. AMBA is outperformed by 75.65% of its industry peers.
  • With a Return On Equity value of -13.50%, AMBA is not doing good in the industry: 72.17% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.6%
ROE -13.5%
ROIC N/A
ROA(3y)-17.42%
ROA(5y)-13.1%
ROE(3y)-21.29%
ROE(5y)-15.9%
ROIC(3y)N/A
ROIC(5y)N/A
AMBA Yearly ROA, ROE, ROICAMBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 -10 20 -20 -30

1.3 Margins

  • The Gross Margin of AMBA (59.58%) is better than 85.22% of its industry peers.
  • In the last couple of years the Gross Margin of AMBA has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for AMBA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.28%
AMBA Yearly Profit, Operating, Gross MarginsAMBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50

7

2. AMBA Health Analysis

2.1 Basic Checks

  • AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AMBA has been increased compared to 1 year ago.
  • AMBA has more shares outstanding than it did 5 years ago.
  • AMBA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMBA Yearly Shares OutstandingAMBA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
AMBA Yearly Total Debt VS Total AssetsAMBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 8.08 indicates that AMBA is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 8.08, AMBA is doing good in the industry, outperforming 66.96% of the companies in the same industry.
  • There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.08
ROIC/WACCN/A
WACC11.46%
AMBA Yearly LT Debt VS Equity VS FCFAMBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 2.66 indicates that AMBA has no problem at all paying its short term obligations.
  • AMBA has a Current ratio (2.66) which is in line with its industry peers.
  • A Quick Ratio of 2.38 indicates that AMBA has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.38, AMBA is in line with its industry, outperforming 56.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.38
AMBA Yearly Current Assets VS Current LiabilitesAMBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M

8

3. AMBA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 464.71% over the past year.
  • The Earnings Per Share has been growing by 13.44% on average over the past years. This is quite good.
  • The Revenue has grown by 37.15% in the past year. This is a very strong growth!
  • Measured over the past years, AMBA shows a quite strong growth in Revenue. The Revenue has been growing by 11.87% on average per year.
EPS 1Y (TTM)464.71%
EPS 3Y-17.65%
EPS 5Y13.44%
EPS Q2Q%18.18%
Revenue 1Y (TTM)37.15%
Revenue growth 3Y4.99%
Revenue growth 5Y11.87%
Sales Q2Q%20.06%

3.2 Future

  • AMBA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.23% yearly.
  • The Revenue is expected to grow by 19.24% on average over the next years. This is quite good.
EPS Next Y23.56%
EPS Next 2Y29.08%
EPS Next 3Y33.13%
EPS Next 5Y48.23%
Revenue Next Year13.62%
Revenue Next 2Y13.34%
Revenue Next 3Y14.06%
Revenue Next 5Y19.24%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMBA Yearly Revenue VS EstimatesAMBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AMBA Yearly EPS VS EstimatesAMBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4

3

4. AMBA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 81.82, which means the current valuation is very expensive for AMBA.
  • AMBA's Price/Earnings ratio is in line with the industry average.
  • AMBA is valuated expensively when we compare the Price/Earnings ratio to 25.51, which is the current average of the S&P500 Index.
  • AMBA is valuated quite expensively with a Price/Forward Earnings ratio of 66.22.
  • AMBA's Price/Forward Earnings is on the same level as the industry average.
  • AMBA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 81.82
Fwd PE 66.22
AMBA Price Earnings VS Forward Price EarningsAMBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMBA indicates a rather cheap valuation: AMBA is cheaper than 81.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 33.98
EV/EBITDA N/A
AMBA Per share dataAMBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMBA does not grow enough to justify the current Price/Earnings ratio.
  • AMBA's earnings are expected to grow with 33.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.47
PEG (5Y)6.09
EPS Next 2Y29.08%
EPS Next 3Y33.13%

0

5. AMBA Dividend Analysis

5.1 Amount

  • AMBA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AMBA Fundamentals: All Metrics, Ratios and Statistics

AMBARELLA INC

NASDAQ:AMBA (4/2/2026, 1:46:28 PM)

50.73

-0.35 (-0.69%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-26
Earnings (Next)05-27
Inst Owners89.32%
Inst Owner Change2%
Ins Owners2.61%
Ins Owner Change3.66%
Market Cap2.18B
Revenue(TTM)390.70M
Net Income(TTM)-79.66M
Analysts77.14
Price Target91.34 (80.05%)
Short Float %5.49%
Short Ratio2.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100.82%
Min EPS beat(2)28.03%
Max EPS beat(2)173.6%
EPS beat(4)4
Avg EPS beat(4)287.07%
Min EPS beat(4)28.03%
Max EPS beat(4)763.65%
EPS beat(8)8
Avg EPS beat(8)179.78%
EPS beat(12)12
Avg EPS beat(12)132.03%
EPS beat(16)16
Avg EPS beat(16)101.68%
Revenue beat(2)2
Avg Revenue beat(2)3.08%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.03%
Revenue beat(4)4
Avg Revenue beat(4)3.08%
Min Revenue beat(4)0.64%
Max Revenue beat(4)5.55%
Revenue beat(8)6
Avg Revenue beat(8)5.33%
Revenue beat(12)6
Avg Revenue beat(12)3.05%
Revenue beat(16)6
Avg Revenue beat(16)1.87%
PT rev (1m)-3.85%
PT rev (3m)-3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)21.96%
EPS NY rev (3m)21.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)3.43%
Revenue NY rev (3m)3.43%
Valuation
Industry RankSector Rank
PE 81.82
Fwd PE 66.22
P/S 5.84
P/FCF 33.98
P/OCF 27.28
P/B 3.7
P/tB 8.79
EV/EBITDA N/A
EPS(TTM)0.62
EY1.22%
EPS(NY)0.77
Fwd EY1.51%
FCF(TTM)1.49
FCFY2.94%
OCF(TTM)1.86
OCFY3.67%
SpS8.68
BVpS13.71
TBVpS5.77
PEG (NY)3.47
PEG (5Y)6.09
Graham Number13.83
Profitability
Industry RankSector Rank
ROA -10.6%
ROE -13.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.58%
FCFM 17.19%
ROA(3y)-17.42%
ROA(5y)-13.1%
ROE(3y)-21.29%
ROE(5y)-15.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 59.03%
Cap/Sales 4.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.38
Altman-Z 8.08
F-Score6
WACC11.46%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)464.71%
EPS 3Y-17.65%
EPS 5Y13.44%
EPS Q2Q%18.18%
EPS Next Y23.56%
EPS Next 2Y29.08%
EPS Next 3Y33.13%
EPS Next 5Y48.23%
Revenue 1Y (TTM)37.15%
Revenue growth 3Y4.99%
Revenue growth 5Y11.87%
Sales Q2Q%20.06%
Revenue Next Year13.62%
Revenue Next 2Y13.34%
Revenue Next 3Y14.06%
Revenue Next 5Y19.24%
EBIT growth 1Y38.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-178.99%
EBIT Next 3Y-2.96%
EBIT Next 5Y68.22%
FCF growth 1Y1813.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1730.16%
OCF growth 3YN/A
OCF growth 5YN/A

AMBARELLA INC / AMBA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AMBARELLA INC?

ChartMill assigns a fundamental rating of 5 / 10 to AMBA.


What is the valuation status for AMBA stock?

ChartMill assigns a valuation rating of 2 / 10 to AMBARELLA INC (AMBA). This can be considered as Overvalued.


How profitable is AMBARELLA INC (AMBA) stock?

AMBARELLA INC (AMBA) has a profitability rating of 2 / 10.


What is the valuation of AMBARELLA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AMBARELLA INC (AMBA) is 81.82 and the Price/Book (PB) ratio is 3.7.


What is the earnings growth outlook for AMBARELLA INC?

The Earnings per Share (EPS) of AMBARELLA INC (AMBA) is expected to grow by 23.56% in the next year.